Lau CC - Search Results

1

Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma.

Nakka M, Allen-Rhoades W, Li Y, Kelly AJ, Shen J, Taylor AM, Barkauskas DA, Yustein JT, Andrulis IL, Wunder JS, Gorlick R, Meltzer PS, Lau CC, Man TK; TARGET osteosarcoma consortium. Nakka M, et al. Among authors: lau cc. Oncotarget. 2017 May 27;8(57):96738-96752. doi: 10.18632/oncotarget.18236. eCollection 2017 Nov 14. Oncotarget. 2017. PMID: 29228567 Free PMC article.

2

p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.

Li Y, Nakka M, Kelly AJ, Lau CC, Krailo M, Barkauskas DA, Hicks JM, Man TK. Li Y, et al. Among authors: lau cc. Cancer Res. 2016 Jul 1;76(13):4002-11. doi: 10.1158/0008-5472.CAN-15-3189. Epub 2016 Apr 19. Cancer Res. 2016. PMID: 27197201 Free PMC article.

3

Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma.

Li Y, Dang TA, Shen J, Perlaky L, Hicks J, Murray J, Meyer W, Chintagumpala M, Lau CC, Man TK. Li Y, et al. Among authors: lau cc. Proteomics. 2006 Jun;6(11):3426-35. doi: 10.1002/pmic.200500472. Proteomics. 2006. PMID: 16673437

4

Personalized care of pediatric cancer patients.

Rabin K, Man TK, Lau CC. Rabin K, et al. Among authors: lau cc. Nestle Nutr Workshop Ser Pediatr Program. 2008;62:173-85; discussion 185-8. doi: 10.1159/000146259. Nestle Nutr Workshop Ser Pediatr Program. 2008. PMID: 18626200 Free article. Review.

5

Plasma proteome predicts chemotherapy response in osteosarcoma patients.

Li Y, Dang TA, Shen J, Hicks J, Chintagumpala M, Lau CC, Man TK. Li Y, et al. Among authors: lau cc. Oncol Rep. 2011 Feb;25(2):303-14. doi: 10.3892/or.2010.1111. Epub 2010 Dec 15. Oncol Rep. 2011. PMID: 21165584

6

Identification and gene expression profiling of tumor-initiating cells isolated from human osteosarcoma cell lines in an orthotopic mouse model.

Rainusso N, Man TK, Lau CC, Hicks J, Shen JJ, Yu A, Wang LL, Rosen JM. Rainusso N, et al. Among authors: lau cc. Cancer Biol Ther. 2011 Aug 15;12(4):278-87. doi: 10.4161/cbt.12.4.15951. Epub 2011 Aug 15. Cancer Biol Ther. 2011. PMID: 21617384 Free PMC article.

7

A systems biology approach reveals common metastatic pathways in osteosarcoma.

Flores RJ, Li Y, Yu A, Shen J, Rao PH, Lau SS, Vannucci M, Lau CC, Man TK. Flores RJ, et al. Among authors: lau cc, lau ss. BMC Syst Biol. 2012 May 28;6:50. doi: 10.1186/1752-0509-6-50. BMC Syst Biol. 2012. PMID: 22640921 Free PMC article.

8

A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LG.

Flores RJ, Kelly AJ, Li Y, Nakka M, Barkauskas DA, Krailo M, Wang LL, Perlaky L, Lau CC, Hicks MJ, Man TK. Flores RJ, et al. Among authors: lau cc. Cancer. 2017 Jan 1;123(1):144-154. doi: 10.1002/cncr.30272. Epub 2016 Aug 16. Cancer. 2017. PMID: 27529817 Free PMC article.

9

Integrated DNA Copy Number and Expression Profiling Identifies IGF1R as a Prognostic Biomarker in Pediatric Osteosarcoma.

Taylor AM, Sun JM, Yu A, Voicu H, Shen J, Barkauskas DA, Triche TJ, Gastier-Foster JM, Man TK, Lau CC. Taylor AM, et al. Among authors: lau cc. Int J Mol Sci. 2022 Jul 21;23(14):8036. doi: 10.3390/ijms23148036. Int J Mol Sci. 2022. PMID: 35887382 Free PMC article.

10

Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma.

Man TK, Lu XY, Jaeweon K, Perlaky L, Harris CP, Shah S, Ladanyi M, Gorlick R, Lau CC, Rao PH. Man TK, et al. Among authors: lau cc. BMC Cancer. 2004 Aug 7;4:45. doi: 10.1186/1471-2407-4-45. BMC Cancer. 2004. PMID: 15298715 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

326 results

Search Page